H1 2024 Life Sciences Update Market Summaries
Germany: Rhine-Neckar Region
View H1 2024 Life Sciences Update
View All Markets
Market Summary
Public & Private Funding (2023/24)
Fast Lab Stats
• The recent changes in the financing environment shook the German real estate market in 2023, but the first half of 2024 shows a stabilization in yields. • The Rhine-Neckar region, particularly Mainz and Heidelberg, has experienced a significant rise in interest from public institutions seeking to increase exposure to the life sciences sector. Existing life sciences campuses will be expanded and receive public funding for growth. The region is emerging as an interregional cluster with life sciences campuses. • The region boasts a prestigious university landscape, including university hospitals in Heidelberg and Mannheim, as well as several key institutions, such as the German Cancer Research Centre, the European Molecular Biology Laboratory and the Max Planck Institute. • Health + Life Sciences Alliance Heidelberg Mannheim, an innovative network of university institutions and research centers, has been established to strengthen the sector within the economic region and to expand it into a leading international cluster in the life sciences. • There are 12 life sciences companies employing more than 10,000 people in Mainz, Heidelberg, Mannheim and Ludwigshafen.
€ Raised (MM)
Company
Deal Type
Completed
Type
150K Total Life Sciences Employment > 64 Life Science Companies > 10 Research facilities/ institutes
NeraCare
Later Stage VC
May 2024
1st Round
€ 21.6
FundaMental Pharma
Seed Round
Apr 2024
1st Round
€ 13.8
FaCellitate
Accelerator/Incubator
Apr 2024
AaviGen
Early Stage
Jul 2023
VC
€ 17.0
Genome Biologics
Later Stage
Jan 2023
VC
WMT
Early Stage
Nov 2023
VC
Representative Investment Sale Transactions (Q3 2022 – Q2 2024)
Address
Type
Volume (€m) Confidential
GLA (sqm)
Date Buyer
Honeycamp Building, Mannheim R&D / Office
11,500 2022 Q4 BNP Paribas REIM
Representative Life Sciences Companies
Life Sciences Labor: Annual Chemist Job Postings
Company
Type
100 150 200 250 300 350 400 450
Representative Lease Transactions (Q3 2022 – Q2 2024)
Company
Address
GLA (sqm) New/Renewal
Type
Quarter
Landlord
Cellzome
Biotechnology
Ascendis Pharma
Grüne Meile, Heidelberg
11,650 New letting
Office/labs
Q3 2022
Max-Jarecki-Stiftung
BD Becton Dickinson Anwerina Deutschland
Medtech
AbbVie Pharmaceutics Knollstraße 50
8,000 Owner Occupier
Office
Q1 2024
AbbVie Pharmaceutics
Pharma
Reckit Beckister
Chemicals
- 50
Roche Diagnostics
Pharma
2019
2020
2021
2022
Bio Degree-Awarding Institutions, Metro Area • Heidelberg University • Ruprecht-Karls-Universität Heidelberg • Johannes Gutenberg-Universität Mainz • Hochschule Mannheim • Karlsruhe Institute of Technology (KIT)
Contributors Benedikt Kiefer benedikt.kiefer@cushwake.com
Simon Jeschioro simon.jeschioro@cushwake.com
Sources: Cushman & Wakefield Research, CoStar, National Institutes of Health (NIH), Lightcast, Pitchbook, Federal Reserve Economic Data (FRED)
CUSHMAN & WAKEFIELD
LIFE SCIENCES UPDATE | 2024 SEPTEMBER
Made with FlippingBook - Online magazine maker